°Ë»ö
ä¿ëÁ¤º¸ ¡ý
ÀÎÀçÁ¤º¸
ÀÓ´ë/ºÐ¾çÁ¤º¸
¾ð·Ð¿¡ ºñÄ£ ¸ÞµðÄÃÀâ
¾î¹Ù¿ô ¸ÞµðÄÃÀâ
°øÁö»çÇ×
ÀÇ·áÃë¾÷Æ÷ÅÐ ¸ÞµðÄÃÀâ
[±Û·Î¹úÁ¦¾à] oncology msl (medical science liasion) ä¿ë°ø°í
                     ¿­±â
ȸ»ç¸í (ÁÖ)½áÄ¡Æ÷¸®´õ½º
¸ðÁýºÐ¾ß ÀϹݰú
¸ðÁýºÎ¹® [±Û·Î¹úÁ¦¾à] oncology msl (medical science liasion) ä¿ë°ø°í
°í¿ëÇüÅ Á¤±ÔÁ÷
¸ðÁýÀοø 0¸í
±Þ¿©Á¶°Ç ¸éÁ¢½Ã ÇùÀÇ
±Ù¹«Áö¿ª ¼­¿ï
°æ·Â °æ·Â 2³âÀÌ»ó
Çз °íµîÇб³ Á¹¾÷
¸¶°¨ÀÏ ¸¶°¨¿Ï·á
Áö¿ø¹æ¹ý ȨÆäÀÌÁö
»ó¼¼³»¿ë
Á¤±ÔÁ÷ ´ëÁ¹ÀÌ»ó °æ·Â2³âÀÌ»ó ÀÚ¿¬°úÇа迭
ÀÇ/¾àÇа迭 ¿µ¾î ¹«°ü ¾à¹«¡¤Á¦¾à > ¾à»ç, Á¦¾à¿¬±¸°³¹ß, cra
°£È£¡¤°£º´ > ¿¬±¸°£È£»ç(crc)
Àǻ硤¼öÀÇ»ç > ÀϹÝÀÇ»ç 0¸í ÇùÀÇ ÈÄ °áÁ¤


[±Û·Î¹úÁ¦¾à] oncology msl (medical science liasion) ä¿ë°ø°í





¸ðÁýºÎ¹® ¹× ÀÚ°Ý¿ä°Ç






















´ã´ç¾÷¹« ÀÚ°Ý¿ä°Ç Àοø

[´ã´ç¾÷¹«]

<scientific operation>

responsible for daiichi-sankyo oncology pipelines and products

attending external national and international scientific meetings

supporting regulatory affairs and pricing & reimbursement

preparing and conducting advisory board meeting or consulting meeting

recommending local kols for global or regional abms and supporting the events

conducting drug access program such as compassionate use program or expanded access program

supporting commercial drug access program such as patient access program in collaboration with marketing

supporting rmp in collaboration with pv and ra 

providing scientific training for sales, marketing, or other internal stakeholders

conducting training or small group seminar, symposium on scientific/medical information to external stakeholder

preparing and conducting medical exhibition booth at medical conference

visiting kols regularly

creating and updating kols list and key society events


< scientific research>

providing recommendations for investigators based on the researcher¡¯s interests and qualifications

identifying opportunities for potential external research collaborations

participating ds-sponsored feasibility process and site initiation visit.

engaging medical query during ds-sponsored trials

conducting and liaison for the clinical investigator-initiated study (iis) and pre-clinical investigator-initiated study (material transfer management)


< scientific communication>


providing oncology medical information with regard to approved products to internal/external stakeholders

responding to unsolicited questions from external stakeholders with regard to pipeline portfolio

meeting with peer group regularly for formal shared learning and

share learning from publications, external medical conferences and other appropriate internal channels 

sharing feedback from external experts including their perspectives on data and medical/scientific needs, views of the general therapeutic area landscape, and clinical experiences

providing recommendations to internal stakeholders for kols and other external parties to serve as consultants or speaker 



< general affairs>

preparing and maintaining msl log or regular internal reporting process

ensuring budget expense and forecasting


[±Ù¹«ºÎ¼­ ¹× Á÷±Þ/Á÷Ã¥]

    ±Ù¹«ºÎ¼­: oncology msl 
    Á÷±Þ/Á÷Ã¥:  ÆÀÀå 


[ÀÚ°Ý¿ä°Ç]

 requirement and experience




  • minimum of 2 years of msl
    experience (mandatory)

  • oncology, hematology and
    rare disease medical affairs experience (preferred)

  • ph d, pharm d, pharmacist
    (preferred)

  • demonstrated strong communication skills, presentation skills, and
    interpersonal skills.

  • expertise in ms office program or digital tools is preferred

  • proficiency in written and spoken english (sufficient to conduct teleconference)

 

[¿ì´ë»çÇ×]

Àü°ø°è¿­: ¾à»ç ¹× °£È£»ç, ÀϹÝÀÇ»ç, ¹Ú»çÇÐÀ§¼ÒÁöÀÚ. 
¿Ü±¹¾î: ¿µ¾î È¸È­°¡´É,µ¶Çذ¡´É,ÀÛ¹®°¡´É


1 ¸í




±Ù¹«Á¶°Ç


  • ±Ù¹«ºÎ¼­: medical affairsÆÀ
  • ±Þ¿©Á¶°Ç: ¿¬ºÀ ÇùÀÇ ÈÄ °áÁ¤




ÀüÇü´Ü°è ¹× Á¦Ãâ¼­·ù


  • ÀüÇü´Ü°è: ¼­·ùÀüÇü > ¸éÁ¢ÁøÇà > 2Â÷¸éÁ¢ÁøÇà > ÃÖÁ¾ÇÕ°Ý
  • Ãß°¡ Á¦Ãâ¼­·ù
    À̷¼­, °æ·Â¼Ò°³¼­ (¿µ¹®, ±¹¹®)




Á¢¼ö¹æ¹ý


2022-06-19 (ÀÏ) 23½Ã59ºÐ±îÁö


  • Á¢¼ö¹æ¹ý: ÀÎÅ©·çÆ® ä¿ë½Ã½ºÅÛ, À̸ÞÀÏ
  • Á¢¼ö¾ç½Ä: ÀÎÅ©·çÆ® À̷¼­, ÀÚÀ¯¾ç½Ä




±âŸ À¯ÀÇ»çÇ×



  • ÀÔ»çÁö¿ø¼­ ¹× Á¦Ãâ¼­·ù¿¡ ÇãÀ§»ç½ÇÀÌ ÀÖÀ» °æ¿ì ä¿ëÀÌ Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.






• responsible for daiichi-sankyo oncology pipelines and products
• attending external national and international scientific meetings
• supporting regulatory affairs and pricing & reimbursement
• preparing and conducting advisory board meeting or consulting meeting
• recommending local kols for global or regional abms and supporting the events
• conducting drug access program such as compassionate use program or expanded access program
• supporting commercial drug access program such as patient access program in collaboration with marketing
• supporting rmp in collaboration with pv and ra
• providing scientific training for sales, marketing, or other internal stakeholders
• conducting training or small group seminar, symposium on scientific/medical information to external stakeholder
• preparing and conducting medical exhibition booth at medical conference
• visiting kols regularly
• creating and updating kols list and key society events

< scientific research>
• providing recommendations for investigators based on the researcher¡¯s interests and qualifications
• identifying opportunities for potential external research collaborations
• participating ds-sponsored feasibility process and site initiation visit.
• engaging medical query during ds-sponsored trials
• conducting and liaison for the clinical investigator-initiated study (iis) and pre-clinical investigator-initiated study (material transfer management)

< scientific communication>

• providing oncology medical information with regard to approved products to internal/external stakeholders
• responding to unsolicited questions from external stakeholders with regard to pipeline portfolio
• meeting with peer group regularly for formal shared learning and
• share learning from publications, external medical conferences and other appropriate internal channels
• sharing feedback from external experts including their perspectives on data and medical/scientific needs, views of the general therapeutic area landscape, and clinical experiences
• providing recommendations to internal stakeholders for kols and other external parties to serve as consultants or speaker


< general affairs>
• preparing and maintaining msl log or regular internal reporting process
• ensuring budget expense and forecasting
À̷¼­, °æ·Â¼Ò°³¼­ (¿µ¹®, ±¹¹®) ¼­¿ïƯº°½Ã > Áß±¸ ÈÞ¹«ÇüÅÂ:ÁÖ5Àϱٹ«
ÈÞ°¡:³âÂ÷
4´ëº¸Çè:±¹¹Î¿¬±Ý,ÀǷẸÇè,»êÀ纸Çè,°í¿ëº¸Çè ~ 2022³â 6¿ù 23ÀÏ ¸ñ¿äÀÏ  (¡æ¸¶°¨±îÁö 29ÀÏ ³²¾Ò½À´Ï´Ù.) ÀÎÅ©·çÆ® ä¿ë½Ã½ºÅÛÀ¸·Î ÀÔ»çÁö¿ø, À̸ÞÀÏ ÀÔ»çÁö¿ø 60 ¼­¿ïƯº°½Ã Áß±¸ ¼­¿ï °æ·Â2³âÀÌ»ó 2022-06-23 02 y
º¹¸®ÈÄ»ý
ÈÞ¹«ÇüÅÂ:ÁÖ5Àϱٹ«
ÈÞ°¡:³âÂ÷
4´ëº¸Çè:±¹¹Î¿¬±Ý,ÀǷẸÇè,»êÀ纸Çè,°í¿ëº¸Çè
Á¦Ãâ¼­·ù
À̷¼­, °æ·Â¼Ò°³¼­ (¿µ¹®, ±¹¹®)
±â¾÷ÁÖ¼Ò : ¼­¿ï °­³²±¸ »ï¼ºµ¿,159-6 Çѱ¹µµ½É°øÇ×Å͹̳Π514
¸¶°¨ÀÏ : 2022³â 06¿ù 23ÀÏ (¸¶°¨¿Ï·á)
ȨÆäÀÌÁö
ÀÌÀüÀ¸·Î ¸ÇÀ§·Î
¡ü
¾ð·Ð¿¡ ºñÄ£ ¸ÞµðÄÃÀâ
¾î¹Ù¿ô ¸ÞµðÄÃÀâ
PC¹öÀü
·Î±×ÀÎ
helper@medicaljob.co.kr
¼­¿ï °­ºÏ±¸ ¼öÀ¯3µ¿ 177-23 (ÁÖ)ÄÄÅ×Å©ÄÁ¼³ÆÃ:À¯Á¾Çö
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£ : ¼­¿ïºÏºÎ Á¦ 2008-01È£
Copyright ¨Ï ¸ÞµðÄÃÀâ. All rights reserved.
¼­¿ï °­ºÏ±¸ ¼öÀ¯3µ¿ 177-23
(ÁÖ)ÄÄÅ×Å©ÄÁ¼³ÆÃ:À¯Á¾Çö
Á÷¾÷Á¤º¸Á¦°ø»ç¾÷½Å°í¹øÈ£
¼­¿ïºÏºÎ Á¦ 2008-01È£
Copyright ¨Ï ¸ÞµðÄÃÀâ. All rights reserved.